This test analyzes genes associated with early-onset coronary heart disease risk, including LDLR, LDLRAP1, PCSK9, ABCG5, ABCG8, and APOB, helps enable early detection and prevention of the disease. Meanwhile, testing genes associated with statins allows for the assessment of the risk of adverse reactions and effectiveness of statin drugs. In addition, this product also includes genetic testing for Alzheimer's disease risk, which helps predict the risk of familial Alzheimer's disease (AD) and identify high-risk individuals, thereby facilitating early prevention and timely intervention
Convenient and flexible
Authoritative and efficient
Sensitive and accurate
People with early-onset coronary heart disease and other cardiovascular diseases
People with a family history of early-onset coronary heart disease or imaging evidence of atherosclerosis
People with hypertension, hyperglycemia and hyperlipidemia (adult serum LDL-C ≥ 4.1 mmol/L)
People whose first-degree relatives have any one or all of the above three conditions
People with hypercholesterolemia and sitosterolemia
People concerned about cardiovascular health
People with cognitive impairment who need risk stratification
People suspected of having Alzheimer's disease and related cognitive impairment disorders
High-risk groups with a family history of Alzheimer's disease
People concerned about neurocognitive diseases and brain health
clinical significance
indicate genetic risk
statin medication guidance
health screening
risk assessment
DNA extraction
quality control
library preparation
library quality control
loading and sequencing
data analysis
report review
report release
7 working days after receiving qualified samples.